EIB signs a SEK 3.5 billion (EUR 325 million) loan agreement with the Swedish Region of Skåne for the modernisation of the university hospital in Malmö.
The financing supports the extension, rehabilitation and reconfiguration of the hospital to provide modern healthcare service in an efficient manner.
The European Investment Bank (EIB) has signed a SEK 3.5 billion loan agreement with the Region of Skane in Southern Sweden to finance the modernisation of the regional University Hospital in Malmö. The hospital is currently providing its services from buildings from the sixties and seventies, which are no longer fit for purpose. Skane’s regional council therefore approved a long-term investment programme to house the core medical services in new facilities and rehabilitate the existing facilities for administrative purposes.
EIB vice-president Thomas Östros commented: “it’s obviously hard to overstate the importance of modern medical facilities right now. However, what makes this project even more interesting are the energy savings that the new building will make possible. Thus, in addition to providing a safer and healthier environment for patients and staff, the new hospital will also positively impact the environment.”
On a technical level, the project supported by the EIB involves the construction of two new buildings with a total surface area of 106,000 m2 and the rehabilitation of about 8,000 m2 within the existing campus of the Malmö University hospital. With the implementation of the project the hospital expects to reduce the energy consumption of the overall campus by 17,200 MWh on a yearly basis. The works are already underway and foreseen to be finished by June 2025.
Region Skåne exists to ensure that the residents of Skåne are healthy and believe in the future. Through collaboration and care across the board, we create the best possible conditions for a healthy life in Skåne – within business, public transport, culture, health and medical care. Together, we make life possible.
The EIB is set to support the development of new treatments for progressive vascular calcification, an area of significant unmet medical need where there are currently no approved treatments. To this end, the EU bank will provide a €20 million loan to Spanish biopharmaceutical company Sanifit, which is developing novel treatments in two disease indications linked to calcification.
The EIB and Italian biotech company EryDel SpA have signed a contract to provide a loan of €30 million to EryDel. This late-stage biotech company aims to develop and commercialise therapies based on its proprietary RBC technology for the treatment of rare diseases. The EU bank’s loan is backed by a guarantee from the European Fund for Strategic Investments (EFSI), the main pillar of the Investment Plan for Europe under which the EIB and the European Commission are working together as strategic partners, with the EIB’s financing operations boosting the competitiveness of the European economy.
The EIB will lend EUR 10 million to Credo Bank, the leading actor on microfinance market in Georgia, and provide more affordable loans to country`s micro, small and medium enterprises (MSME), predominantly from the agriculture sector. This is the second loan granted under the EIB`s Georgia Outreach Initiative. Launched in December 2019 the Initiative improves financial inclusion and access to finance for underserved MSMEs in Georgia by supporting smaller banks in the country to improve their service offers.